通过全表型关联研究评估多基因与表型风险预测对多囊卵巢综合征的作用
研究利用124 852名个体的电子健康记录,将多基因风险评分与多囊卵巢综合征(PCOS)组分表型结合构建多基因与表型风险评分(PPRS),在欧洲、非洲和多祖先参与者中伪R²分别提高0.228(61.5倍)、0.224(58.8倍)、0.211(57.0倍)。基于PRS的全表型关联研究(PheWAS)发现PCOS与肥胖、糖尿病等代谢内分泌结局存在高度共享生物学,其中病态肥胖、2型糖尿病、高胆固醇血症、脂质代谢紊乱、高血压和睡眠呼吸暂停达到全表型显著性。
要点
- PPRS在欧洲、非洲和多祖先人群中检测PCOS的伪R²分别提高0.228、0.224、0.211。
- 基于PRS的PheWAS显示PCOS与肥胖、糖尿病等代谢内分泌结局高度共享生物学。
- 病态肥胖、2型糖尿病、高胆固醇血症、脂质代谢紊乱、高血压和睡眠呼吸暂停达全表型显著性。
核心结论
- 多基因风险评分(PRS)可用于多因素疾病如PCOS的患者分层和风险预测,并在不同遗传背景中扩展了方法学效用。
- 利用电子健康记录中的个体基因组-表型数据,基于PRS的多基因预测为发现与PCOS发病相关的多效性表型网络提供了机会。
研究设计与样本
- 利用124 852名个体的电子健康记录,将多基因风险评分(PRS)与PCOS组分表型结合,开发多基因与表型风险评分(PPRS)的PCOS风险预测算法。
- 在不同祖先人群中评估PPRS的预测能力,并开展基于PRS的全表型关联研究(PheWAS)以评估PCOS风险升高的表型组表达。
主要发现
- 整合多基因预测在欧洲、非洲和多祖先参与者中检测PCOS的平均性能(伪R²)分别较零模型提高0.228(61.5倍)、0.224(58.8倍)、0.211(57.0倍)。
- 基于PRS的PheWAS发现PCOS与一系列代谢和内分泌结局存在高度共享生物学,尤其是肥胖和糖尿病。
- 病态肥胖、2型糖尿病、高胆固醇血症、脂质代谢紊乱、高血压和睡眠呼吸暂停达到全表型显著性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: As many as 75% of patients with polycystic ovary syndrome (PCOS) are estimated to be unidentified in clinical practice. OBJECTIVE: Utilizing polygenic risk prediction, we aim to identify the phenome-wide comorbidity patterns characteristic of PCOS to improve accurate diagnosis and preventive treatment. DESIGN, PATIENTS, AND METHODS: Leveraging the electronic health records (EHRs) of 124 852 individuals, we developed a PCOS risk prediction algorithm by combining polygenic risk scores (PRS) with PCOS component phenotypes into a polygenic and phenotypic risk score (PPRS). We evaluated its predictive capability across different ancestries and perform a PRS-based phenome-wide association study (PheWAS) to assess the phenomic expression of the heightened risk of PCOS. RESULTS: The integrated polygenic prediction improved the average performance (pseudo-R2) for PCOS detection by 0.228 (61.5-fold), 0.224 (58.8-fold), 0.211 (57.0-fold) over the null model across European, African, and multi-ancestry participants respectively. The subsequent PRS-powered PheWAS identified a high level of shared biology between PCOS and a range of metabolic and endocrine outcomes, especially with obesity and diabetes: "morbid obesity", "type 2 diabetes", "hypercholesterolemia", "disorders of lipid metabolism", "hypertension", and "sleep apnea" reaching phenome-wide significance. CONCLUSIONS: Our study has expanded the methodological utility of PRS in patient stratification and risk prediction, especially in a multifactorial condition like PCOS, across different genetic origins. By utilizing the individual genome-phenome data available from the EHR, our approach also demonstrates that polygenic prediction by PRS can provide valuable opportunities to discover the pleiotropic phenomic network associated with PCOS pathogenesis.
引用
- Joo YY, Actkins K, Pacheco JA, et al. A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies. J Clin Endocrinol Metab. 2020. PMID: 31917831. doi:10.1210/clinem/dgz326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。